Zobrazeno 1 - 10
of 156
pro vyhledávání: '"G, Nowakowski"'
Autor:
F Lansigan, DJ Andorsky, M Coleman, A Yacoub, JMM Md, SR Fanning, KS Kolibaba, C Reynolds, G Nowakowski, M Gharibo, E Ahn, J Li, MJ Rummel, JP Sharman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S105-S106 (2021)
Objectives: Lenalidomide combined with rituximab (R2) has shown complimentary clinical activity and is a tolerable regimen in both untreated and relapsed or refractory (R/R) patients (pts) with indolent non-Hodgkin lymphoma. Pts with advanced age at
Externí odkaz:
https://doaj.org/article/f31add9cf54d44adb14bad41e86b3617
Autor:
M Coleman, DJ Andorsky, A Yacoub, JM Melear, SR Fanning, KS Kolibaba, F Lansigan, C Reynolds, G Nowakowski, M Gharibo, E Ahn, J Li, MJ Rummel, JP Sharman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S98- (2021)
Objectives: Relapse is expected when treating patients with follicular lymphoma (FL) and marginal zone lymphoma (MZL), with a shortened response associated with each relapse. Lenalidomide combined with rituximab (R2) has shown enhanced activity, with
Externí odkaz:
https://doaj.org/article/c4a2564782f24e20971aeb2d2c6d05d0
Autor:
E. Joffe, G. Nowakowski, H. Tun, A. Rosenthal, M. Lunning, R. Ramchandren, C.-C. Li, L. Zhou, E. Martinez, R. von Roemeling, R. Earhart, M. McMahon, I. Isufi, L. Leslie
Publikováno v:
HemaSphere, Vol 6, Pp 1011-1012 (2022)
Externí odkaz:
https://doaj.org/article/06334392b0a64cde9f47e9d7e5d5e893
Autor:
H. Audil, M. Shah, K. Rabe, W. Ding, P. Hampel, N. N. Bennani, T. Call, C. Hanson, Y. Wang, A. Koehler, S. Schwager, J. Leis, S. Slager, S. Kenderian, A. Al-Kali, G. Nowakowski, M. Shi, S. Parikh
Publikováno v:
HemaSphere, Vol 6, Pp 984-985 (2022)
Externí odkaz:
https://doaj.org/article/373fa0eb310744789df5fb49702044d9
Autor:
A. Bock, K. Poonsombudlert, M. Larson, J. Gile, R. Tawfiq, S. Maliske, M. Maurer, J. Cerhan, X. Andrade-gonzalez, A. Saliba, J. Paludo, D. Inwards, S. Ansell, T. Witzig, T. Habermann, B. Link, S. Ayyappan, G. Nowakowski, U. Farooq, Y. Wang
Publikováno v:
HemaSphere, Vol 6, Pp 986-987 (2022)
Externí odkaz:
https://doaj.org/article/e7c334dc33d343dea5fd4b2bf679d84a
Autor:
N. L. Bartlett, C. A. Yasenchak, K. K. Ashraf, W. N. Harwin, J. Orcutt, P. Kuriakose, P. L. Zinzani, A. Mamidipalli, K. Fenton, C. Glenn, G. Nowakowski
Publikováno v:
HemaSphere, Vol 6, Pp 1064-1065 (2022)
Externí odkaz:
https://doaj.org/article/0186ace057a94510ac5556939fac7551
Autor:
A. Bock, R. Mwangi, M. Maurer, J. Cerhan, W. L. Ng, R. King, N. N. Bennani, S. Ansell, T. Habermann, T. Witzig, Y. Wang, G. Nowakowski
Publikováno v:
HemaSphere, Vol 6, Pp 1054-1055 (2022)
Externí odkaz:
https://doaj.org/article/62de0cc930ab412f81bd24425133c622
Publikováno v:
HemaSphere, Vol 6, Pp 1944-1945 (2022)
Externí odkaz:
https://doaj.org/article/d81f6b0489e447d39c494ac9dc76f1c7
Autor:
D.J. Andorsky, M. Coleman, A. Yacoub, J.M. Melear, S.R. Fanning, K.S. Kolibaba, F. Lansigan, C. Reynolds, G. Nowakowski, A.L. Et
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 222- (2020)
Externí odkaz:
https://doaj.org/article/194af21a15304370a7c04678fc09775f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.